Sarcopenic Obesity and Risk of New Onset Depressive Symptoms in Older Adults: English Longitudinal Study of Ageing
Overview
Authors
Affiliations
Background: We examined the role of sarcopenic obesity as a risk factor for new-onset depressive symptoms over 6-year follow-up in a large sample of older adults.
Methods: The sample comprised 3862 community dwelling participants (1779 men, 2083 women; mean age 64.6±8.3 years) without depressive symptoms at baseline, recruited from the English Longitudinal Study of Ageing. At baseline and 4-year follow-up, handgrip strength (kg) of the dominant hand was assessed using a hand-held dynamometer, as a measure of sarcopenia. The outcome was new onset depressive symptoms at 6-year follow-up, defined as a score of ⩾4 on the 8-item Centre of Epidemiological Studies Depression scale. Sarcopenic obesity was defined as obese individuals (body mass index ⩾30 kg m(-)(2)) in the lowest tertile of sex-specific grip strength (<35.3 kg men; <19.6 kg women).
Results: Using a multivariable logistic regression model, the risk of depressive symptoms was greatest in obese adults in the lowest tertile of handgrip strength (odds ratio (OR), 1.79, 95% confidence interval (CI), 1.10, 2.89) compared with non-obese individuals with high handgrip strength. Participants who were obese at baseline and had a decrease of more than 1 s.d. in grip strength over 4-year follow-up were at greatest risk of depressive symptoms (OR=1.97, 95% CI, 1.22, 3.17) compared with non-obese with stable grip strength.
Conclusions: A reduction in grip strength was associated with higher risk of depressive symptoms in obese participants only, suggesting that sarcopenic obesity is a risk factor for depressive symptoms.
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.
Park J, Chung Y, Song J, Kil K, Lee H, Chae J J Menopausal Med. 2025; 30(3):143-151.
PMID: 39829191 PMC: 11745730. DOI: 10.6118/jmm.24004.
Michels G, Mattos Rosa G, Renke G, Starling-Soares B Life (Basel). 2024; 14(11).
PMID: 39598182 PMC: 11595699. DOI: 10.3390/life14111383.
Ohta T, Kojima N, Osuka Y, Sasai H Nutrients. 2024; 16(14).
PMID: 39064622 PMC: 11279862. DOI: 10.3390/nu16142179.
Understanding the development of sarcopenic obesity.
Gross D, Cheever C, Batsis J Expert Rev Endocrinol Metab. 2023; 18(6):469-488.
PMID: 37840295 PMC: 10842411. DOI: 10.1080/17446651.2023.2267672.
Mendorf S, Schonenberg A, Heimrich K, Prell T Front Med (Lausanne). 2023; 10:1260371.
PMID: 37780562 PMC: 10536140. DOI: 10.3389/fmed.2023.1260371.